Free Trial

Week Ahead (1/2)

UK
  • Headlines surrounding whether the June 21 reopening will go ahead as planned and Friday's April GDP monthly data will be the highlights for the UK this week while external events will continue to have a large bearing on UK markets.
  • Saturday's Telegraph reported that over-40s will have their second vaccine dose within eight weeks of the first (in a move that echoes the change for over-50s and is instead of the 11-12 week gap originally planned) with the government considering pushing back the next set of lifting of restrictions to July 5 (instead of June 21) with all over-40s to have been offered a second vaccine by July 5. The week ahead is seen as critical with children returning to school following the half term break and the government hoping that with people having been moving around the country that more cases of the Delta variant do not cause a sharp increase in Covid-19 cases. Cases in the week to 3 June had already increased to just over 30,000 up from the 20,000 the prior week but thankfully there is not a corresponding rise in hospital admissions yet. With over 50% of the adult population having had both doses of the vaccine and 75% having had one dose, the hope is that hospital admissions will not pick up substantially and that most of these new cases will turn out to be relatively mild or asymptomatic. Health Secretary Matt Hancock told the BBC that the government is "absolutely open" to delaying the planned June 21 reopening saying that the Delta variant was making the decision on whether to proceed as planned on June 21 as "more challenging".

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.